In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Enabling evidence-based study endpoint selection
In this article from Applied Clinical Trials, Marcelo Alves Favaro, Associate Outcomes Researcher, MAPI Research Trust, Caprice Sassano, Research Lead - Applied Sciences at HumanFirst and Roya Sherafat, Scientific Director, MAPI Research Trust explore how digital health technologies and patient-centred assessments can be evaluated side-by-side to rapidly select the right tool and the right measures, ultimately reducing patient burden.
-
Overcoming challenges in obesity-related clinical trials
Recent advancements in obesity treatments have spotlighted the field for healthcare providers and developers. In this article from Drug Discovery World, ICON experts share insights on the clinical trials landscape for obesity and why patient centricity is key to overcoming common challenges in the sector.
-
Advancing clinical research through effective data delivery
In this article from The Scientist, Rose Kidd, President of Global Operations Delivery, explains how clinical researchers ensure impeccable data collection and delivery in increasingly complex trials.
-
Clinical supply CDMOs rejig service models
In this article from Contract Pharma, Kelly Corkey, Director, Clinical Supplies Management, IRT provides commentary on how clinical supply services are changing as next-gen biotherapeutics and direct-to-patient trials transform the clinical research arena, disrupting the traditional supply models.
-
Data integration frameworks key for embracing big data’s potential
Rick Rosenthal and Paula Fullman of Symphony Health, an ICON plc company, explain how to navigate the complexities and challenges of the evolving digital landscape of healthcare data in this article from PharmaTimes.
-
Winners recognised amid record entries for the PwC Business Post Sustainable Business Awards
This article in the Business Post lists ICON as the winner of the Social and Equality Business of the Year Award category of the 2024 PwC Business Post Sustainable Business Awards.
-
Clinical development strategy in oncology
In Dr Tanja Obradovic's article in The Cancer Letter, she discusses how to navigate early clinical development and support robust registrational strategy and late-stage development in oncology.
-
Seeking solutions for more representative populations
This article in Applied Clinical Trials by Tinaya Gray, Global Head of Diversity & Inclusion in Clinical Trials discusses how technology can offer opportunities to leverage tailored solutions that can help drive inclusive diversity in clinical research, to help increase participation from underrepresented patient populations.
-
Insight into obesity-related clinical research
In an interview with Contract Pharma, ICON’s Adrienne Stoudenmire and Alan Baldridge discuss current obesity R&D trends, challenges associated with obesity-related clinical research, and opportunities in this sector.
-
The State of Obesity-Related Clinical Research: A Q&A session with ICON's Simon Bruce
ICON’s Simon Bruce, Vice President of Internal Medicine and Drug Development Solutions sits down for a Q&A with Pharmaceutical Executive and gives an overview on the obesity survey carried out by ICON in January 2024 and what it suggests about the state of the obesity-related pipeline.
